| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.27 | 4e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-06 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |